Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $949,190 - $1.08 Million
5,500 New
5,500 $1.07 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $24.2 Million - $29.2 Million
146,100 Added 730.5%
166,100 $28.1 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $3.03 Million - $4 Million
20,000 New
20,000 $3.95 Million
Q4 2022

Feb 10, 2023

BUY
$131.14 - $157.47 $1.31 Million - $1.57 Million
10,000 New
10,000 $1.47 Million
Q2 2021

Sep 13, 2021

BUY
$155.9 - $187.99 $2.29 Million - $2.76 Million
14,700 New
14,700 $2.74 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.